SEC Comment Letter 0000000000-23-005157 to Monogram Technologies Inc. (MGRM) (CIK 0001769759)
Monogram Technologies Inc. (MGRM) (CIK 0001769759)
Date: May 15, 2023 · CIK: 0001769759 · Accession: 0000000000-23-005157
AI Filing Summary & Sentiment
File numbers found in text: 024-12084
Letter
United States securities and exchange commission logo May 15, 2023 Benjamin Sexson Chief Executive Officer Monogram Orthopaedics, Inc. 3913 Todd Lane Austin, TX 78744 Re:Monogram Orthopaedics Inc. Post Qualification Amendment No. 1 to Offering Statement on Form 1-A Filed May 11, 2023 File No. 024-12084 Dear Benjamin Sexson: We have reviewed your post qualification amendment and do not have any comments. We will consider qualifying your offering statement at your request. If a participant in your offering is required to clear its compensation arrangements with FINRA, please have FINRA advise us that it has no objections to the compensation arrangements prior to qualification. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Conlon Danberg at 202-551-4466 or Celeste Murphy at 202-551-3257 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Andrew Stephenson, Esq.
Show Raw Text
United States securities and exchange commission logo
May 15, 2023
Benjamin Sexson
Chief Executive Officer
Monogram Orthopaedics, Inc.
3913 Todd Lane
Austin, TX 78744
Re:Monogram Orthopaedics Inc.
Post Qualification Amendment No. 1 to Offering Statement on Form 1-A
Filed May 11, 2023
File No. 024-12084
Dear Benjamin Sexson:
We have reviewed your post qualification amendment and do not have any comments.
We will consider qualifying your offering statement at your request. If a participant in
your offering is required to clear its compensation arrangements with FINRA, please have
FINRA advise us that it has no objections to the compensation arrangements prior to
qualification.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Please contact Conlon Danberg at 202-551-4466 or Celeste Murphy at 202-551-3257
with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Andrew Stephenson, Esq.